Exascale Labs Holdings Inc. Class A Common Stock (XLAB) FinancialsXLABExascale Labs Holdings Inc. Class A Common Stock

Evaluating the bottom line, Exascale Labs Holdings Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of 5.81%, provide a clear picture of how effectively XLAB converts its operational activities into shareholder value.

In the context of the broader market, XLAB competes directly with industry leaders such as IGAC and ARCL. With a market capitalization of $122.23M, it holds a significant position in the sector. When comparing efficiency, XLAB's gross margin of N/A stands against IGAC's N/A and ARCL's N/A. Such benchmarking helps identify whether Exascale Labs Holdings Inc. is trading at a premium or discount relative to its financial performance.

The company has shown a positive trend in revenue, with Q2 2026 revenue at 4,261,468 USD and net income of 1,890,418 USD, indicating improving financial health.